Delivery Order SPE2DR25D2009-SPE2DR26FJ6N2

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 9, 2026, with a ceiling value of $1,049.72 for supply of Quillivant XR 25 mg/5 ml suspension, 120 ml. Place of performance is Conshohocken, PA. Ultimate completion date is February 10, 2026. The order is firm fixed price with no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 10, 2026, for Quillivant XR 25 mg/5 ml suspension (180 ml), with a ceiling value of $2,066.34.</p> <p>Place of performance is Conshohocken, PA. The order has a firm fixed price structure and an ultimate completion date of February 11, 2026. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 5, 2026, with a ceiling value of $5,343.66 for supply of Quillivant XR 25mg.</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 6, 2026 and carries firm fixed-price terms with no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 6, 2026, with a ceiling value of $6,887.37 for Quillivant XR 25 mg/5 mL suspension (60 mL).</p> <p>Place of performance is Conshohocken, PA. The order has an ultimate completion date of February 9, 2026. Pricing is firm fixed price. No set-aside was used.</p>

<p>The Defense Logistics Agency issued a $4,602.76 delivery order to Amerisourcebergen Drug Corp on February 9, 2026, for Quillivant XR 25 mg/5 ml suspension (150 ml).</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with an ultimate completion date of February 10, 2026. No set-aside was used.</p>

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, for $2,550.48 to supply Quillivant XR 25 mg/5 ml suspension (60 ml). Place of performance is Conshohocken, PA. The ultimate completion date is February 9, 2026. This is a firm fixed-price delivery order with no set-aside. The order was issued under the DLA Troop Support Medical IDC, an indefinite delivery contract supporting pharmaceutical and medical supply procurement for military...

<p>The Defense Logistics Agency issued a $8,130.85 delivery order to Amerisourcebergen Drug Corp on February 5, 2026, for QUILLIVANT XR 25 MG/5 ML SUSP 120ML pharmaceutical supply.</p> <p>Place of performance is Conshohocken, PA 19428. The order carries a firm fixed price and an ultimate completion date of February 6, 2026. No set-aside was used.</p>

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120ml quantities, valued at $1,526.88. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of December 1, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued...

The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Quillivant XR 25 mg/5 ml suspension in 120 ml quantities, valued at $3,153.38. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for completion by April 25, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...

The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on February 6, 2026, with a ceiling value of $1,190.09 for Quillivant XR 25 mg/5 ml suspension (180 ml). The order is issued under the DLA Troop Support Medical IDC held by the parent company Cencora, Inc., valued at up to $999,999,999.00 through December 2031. This indefinite delivery contract provides pharmaceutical products and medical supplies to support military healthcare programs globally, covering...